A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

AT-7687 is designed to offer a new approach to obesity treatment by targeting the GIPR, a mechanism with strong genetic and clinical validation for its potential to improve weight loss efficacy and ...

There is widespread bipartisan support for modernizing Medicare’s approach to obesity treatment. Medical organizations, advocacy groups, and the general public recognize the need for change. Surveys ...

This limits the generalizability of findings to broader populations, particularly those with obesity or metabolic disorders. The findings align with previous research showing that intermittent fasting ...